Elucid

Elucid

Medical Devices, 2 Park PLZ, Boston, Massachusetts, 02116, United States, 51-200 Employees

elucid.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 61********

Who is ELUCID

Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for pat...

Read More

map
  • 2 Park PLZ, Boston, Massachusetts, 02116, United States Headquarters: 2 Park PLZ, Boston, Massachusetts, 02116, United States
  • 2013 Date Founded: 2013
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 2834 | NAICS Code: 999990 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ELUCID

Elucid Org Chart and Mapping

Employees

Anton Lisun

Information Technology Manager

Bennett Newton

Strategy/Operations Intern

Hiral Vora

Lead Quality and Regulatory Affairs Specialist

Wayne Zhao

Scientific Programmer

Adrian Tsang

Principal Image Processing Engineer

David Chen

Strategic Finance Intern

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Elucid

Answer: Elucid's headquarters are located at 2 Park PLZ, Boston, Massachusetts, 02116, United States

Answer: Elucid's phone number is 61********

Answer: Elucid's official website is https://elucid.com

Answer: Elucid's revenue is $25 Million to $50 Million

Answer: Elucid's SIC: 2834

Answer: Elucid's NAICS: 999990

Answer: Elucid has 51-200 employees

Answer: Elucid is in Medical Devices

Answer: Elucid contact info: Phone number: 61******** Website: https://elucid.com

Answer: Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (Virtual Transcriptomics). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access